KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Net Income (2020 - 2025)

Ginkgo Bioworks Holdings' Net Income history spans 6 years, with the latest figure at -$80.8 million for Q4 2025.

  • For Q4 2025, Net Income rose 24.91% year-over-year to -$80.8 million; the TTM value through Dec 2025 reached -$312.8 million, up 42.83%, while the annual FY2025 figure was -$312.8 million, 42.83% up from the prior year.
  • Net Income reached -$80.8 million in Q4 2025 per DNA's latest filing, roughly flat from -$80.8 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$54.5 million in Q2 2021 to a low of -$1.6 billion in Q4 2021.
  • Average Net Income over 5 years is -$284.8 million, with a median of -$169.5 million recorded in 2022.
  • Peak YoY movement for Net Income: tumbled 3503.81% in 2021, then skyrocketed 89.22% in 2022.
  • A 5-year view of Net Income shows it stood at -$1.6 billion in 2021, then surged by 89.22% to -$173.1 million in 2022, then decreased by 22.31% to -$211.7 million in 2023, then skyrocketed by 49.2% to -$107.5 million in 2024, then rose by 24.91% to -$80.8 million in 2025.
  • Per Business Quant, the three most recent readings for DNA's Net Income are -$80.8 million (Q4 2025), -$80.8 million (Q3 2025), and -$60.3 million (Q2 2025).